Literature DB >> 844513

Cannabinoid penetration and chronic effects in the eye.

K Green, J F Bigger, K Kim, K Bowman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 844513     DOI： 10.1016/0014-4835(77)90260-3

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  8 in total

1.  Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.

Authors:  Tushar Hingorani; Waseem Gul; Mahmoud Elsohly; Michael A Repka; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2011-10-11       Impact factor: 3.534

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

Authors:  Matt H Oltmanns; Sandeep S Samudre; Ivan G Castillo; Alireza Hosseini; Aron H Lichtman; Robert C Allen; Frank A Lattanzio; Patricia B Williams
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

Review 4.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

5.  The influence of delta 9-tetrahydrocannabinol on intraocular pressure in the anaesthetized cat.

Authors:  H C Innemee; A J Hermans; P A van Zwieten
Journal:  Doc Ophthalmol       Date:  1980-04-15       Impact factor: 2.379

6.  Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations.

Authors:  Tushar Hingorani; Goutham R Adelli; Nagendra Punyamurthula; Waseem Gul; Mahmoud A Elsohly; Michael A Repka; Soumyajit Majumdar
Journal:  Pharm Res       Date:  2013-06-05       Impact factor: 4.200

7.  Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.

Authors:  Goutham R Adelli; Prakash Bhagav; Pranjal Taskar; Tushar Hingorani; Sara Pettaway; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

8.  Δ9-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits.

Authors:  Pranjal S Taskar; Akash Patil; Prit Lakhani; Eman Ashour; Waseem Gul; Mahmoud A ElSohly; Brian Murphy; Soumyajit Majumdar
Journal:  Transl Vis Sci Technol       Date:  2019-09-19       Impact factor: 3.283
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.